calpain-inhibitor-iii and Acute-Disease

calpain-inhibitor-iii has been researched along with Acute-Disease* in 2 studies

Other Studies

2 other study(ies) available for calpain-inhibitor-iii and Acute-Disease

ArticleYear
Generation and Role of Calpain-Cleaved 17-kDa Tau Fragment in Acute Ischemic Stroke.
    Molecular neurobiology, 2021, Volume: 58, Issue:11

    Stroke is the leading cause of permanent disability and death in the world. The therapy for acute stroke is still limited due to the complex mechanisms underlying stroke-induced neuronal death. The generation of a 17-kDa neurotoxic tau fragment was reported in Alzheimer's disease but it has not been well studied in stroke. In this study, we observed the accumulation of 17-kDa tau fragment in cultured primary neurons and media after oxygen-glucose deprivation/reperfusion (OGD/R) treatment that could be diminished by the presence of a calpain inhibitor. This calpain-mediated proteolytic tau fragment was also detected in brain tissues from middle cerebral artery occlusion-injured rats and acute ischemic stroke patients receiving strokectomy, and human plasma samples collected within 48 h after the onset of stroke. The mass spectrometry analysis of this 17-kDa fragment identified 2 peptide sequences containing 195-224 amino acids of tau, which agrees with the previously reported tau

    Topics: Acute Disease; Animals; Brain Chemistry; Brain Ischemia; Calpain; Cell Shape; Cells, Cultured; Dipeptides; Enzyme Activation; Genes, Reporter; Humans; Infarction, Middle Cerebral Artery; MAP Kinase Signaling System; Nerve Tissue Proteins; Neurons; Peptide Fragments; Primary Cell Culture; Protein Processing, Post-Translational; Rats; Recombinant Proteins; tau Proteins

2021
Calpain inhibition preserves talin and attenuates right heart failure in acute pulmonary hypertension.
    American journal of respiratory cell and molecular biology, 2012, Volume: 47, Issue:3

    Right heart failure from right ventricular (RV) pressure overload is a major cause of morbidity and mortality, but its mechanism is incompletely understood. We tested the hypothesis that right heart failure during 4 hours of RV pressure overload is associated with alterations of the focal adhesion protein talin, and that the inhibition of calpain attenuates RV dysfunction and preserves RV talin. Anesthetized open-chest pigs treated with the calpain inhibitor MDL-28170 (n = 20) or inactive vehicle (n = 23) underwent 4 hours of RV pressure overload by pulmonary artery constriction (initial RV systolic pressure, 64 ± 1 and 66 ± 1 mm Hg in MDL-28170 and vehicle-treated pigs, respectively). Progressive RV contractile dysfunction was attenuated by MDL-28170: after 4 hours of RV pressure overload, RV systolic pressure was 44 ± 4 mm Hg versus 49 ± 6 mm Hg (P = 0.011), and RV stroke work was 72 ± 5% of baseline versus 90 ± 5% of baseline, (P = 0.027), in vehicle-treated versus MDL-28170-treated pigs, respectively. MDL-28170 reduced the incidence of hemodynamic instability (death or systolic blood pressure of < 85 mm Hg) by 46% (P = 0.013). RV pressure overload disrupted talin organization. MDL-28170 preserved talin abundance in the RV free wall (P = 0.039), and talin abundance correlated with the maintenance of RV free wall stroke work (r = 0.58, P = 0.0039). α-actinin and vinculin showed similar changes according to immunohistology. Right heart failure from acute RV pressure overload is associated with reduced talin abundance and disrupted talin organization. Calpain inhibition preserves the abundance and organization of talin and RV function. Calpain inhibition may offer clinical utility in treating acute cor pulmonale.

    Topics: Actinin; Acute Disease; Animals; Calpain; Dipeptides; Electrophoresis, Polyacrylamide Gel; Heart Failure; Heart Ventricles; Hypertension, Pulmonary; Swine; Talin

2012